BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70
50561 results:

  • 1. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic leukemia in Mexico.
    Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
    JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid leukemia.
    Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
    JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
    Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
    Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Oncogene
    Pastoors D; Havermans M; Mulet-Lazaro R; Brian D; Noort W; Grasel J; Hoogenboezem R; Smeenk L; Demmers JAA; Milsom MD; Enver T; Groen RWJ; Bindels E; Delwel R
    Sci Adv; 2024 May; 10(20):eadk9076. PubMed ID: 38748792
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study.
    Xin F; Yu YH; Shen XL; Zhang GX
    Hematology; 2024 Dec; 29(1):2350319. PubMed ID: 38748459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Drug Analysis of Voriconazole Combined with Granulocyte Colony Stimulating Factor.
    Zhang X; Li R; Wang H; Li H; Wu Y
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747920
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ragnarsson C; Yang M; Moura-Castro LH; Aydın E; Gunnarsson R; Olsson-Arvidsson L; Lilljebjörn H; Fioretos T; Duployez N; Zaliova M; Zuna J; Castor A; Johansson B; Paulsson K
    Genes Chromosomes Cancer; 2024 May; 63(5):e23242. PubMed ID: 38738968
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
    Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
    J Genet; 2024; 103():. PubMed ID: 38736250
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cepharanthine synergistically promotes methylprednisolone pharmacodynamics against human peripheral blood mononuclear cells possibly via regulation of P-glycoprotein/glucocorticoid receptor translocation.
    Xu W; Chen S; Wang X; Min J; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    BMC Complement Med Ther; 2024 May; 24(1):186. PubMed ID: 38734604
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy of surgical treatment of perianal infection in patients with hematological malignancy.
    He J; Ni Z; Li Z
    Medicine (Baltimore); 2024 May; 103(19):e38082. PubMed ID: 38728504
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children.
    Zhang N; Li H; Wang D; Wang Z; Zhu JS; Chen K; Jiang H; Shao JB; Cai C
    Clin Epigenetics; 2024 May; 16(1):63. PubMed ID: 38725010
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Systematic analysis of mucosal-associated invariant T cells in haematological malignancies.
    Bacova B; Cierny J; Nemcekova L; Smetanova/Brozova J; Novak J
    Scand J Immunol; 2024 Jun; 99(6):e13364. PubMed ID: 38720521
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Regulation of cytokine and chemokine expression by histone lysine methyltransferase MLL1 in rheumatoid arthritis synovial fibroblasts.
    Okamoto K; Araki Y; Aizaki Y; Tanaka S; Kadono Y; Mimura T
    Sci Rep; 2024 May; 14(1):10610. PubMed ID: 38719857
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]    [Full Text] [Related]  

  • 17. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
    Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
    [No Abstract]    [Full Text] [Related]  

  • 18. [Preparation of a dual-specific antibody targeting human CD123 and exploration of its anti-acute myeloid leukemia effects].
    Zhou T; Chen ML; Zhang CY; Liu XY; Wang ZZ; Xing HY; Tang KJ; Tian Z; Rao Q; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):225-232. PubMed ID: 38716593
    [No Abstract]    [Full Text] [Related]  

  • 19. [Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
    Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
    [No Abstract]    [Full Text] [Related]  

  • 20. Phosphatidylserine and Tyro3-Axl-Mertk Receptor Tyrosine Kinase level detection in plasma and on plasma-derived extracellular vesicle surface in chronic lymphocytic leukemia.
    Bay M; Seval GC; Coskun O; Gurman G; Erdas NO
    Cell Biochem Funct; 2024 Jun; 42(4):e4035. PubMed ID: 38715180
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2529.